Operation against those who market expired cancer drugs

Turkish authorities launched a fresh operation in a probe into expired cancer drugs allegedly being repackaged and sold as in-date, ordering the detention of 15 new suspects and search-and-seizure actions at 3 business premises. Investigators claim the medicines were placed in new boxes and patient leaflets to disguise passed expiration dates, then sold domestically and abroad. The case matters because it raises quality and safety concerns over the supply chain for oncology treatments, a high-value segment for drugmakers and distributors. What to watch next is whether the searches yield further evidence and whether additional suspects or companies are drawn into the investigation.